Refine
Year of publication
Document Type
- Article (384)
- Preprint (124)
- Conference Proceeding (2)
- Part of Periodical (2)
Has Fulltext
- yes (512)
Is part of the Bibliography
- no (512)
Keywords
- BESIII (9)
- LHC (9)
- Branching fraction (7)
- e +-e − Experiments (7)
- ALICE experiment (4)
- Lepton colliders (4)
- Particle and Resonance Production (4)
- Quarkonium (4)
- Quasi-free scattering (4)
- ALICE (3)
- Charm Physics (3)
- Charmed mesons (3)
- Elastic scattering (3)
- Electroweak interaction (3)
- Experimental nuclear physics (3)
- Experimental particle physics (3)
- Hadronic decays (3)
- Inverse kinematics (3)
- Polarization (3)
- Psychiatric disorders (3)
- Spectroscopic factors (3)
- e+-e− Experiments (3)
- pp collisions (3)
- AML (2)
- Abdominal aortic aneurysm (2)
- Abdominelles Aortenaneurysma (2)
- Beauty production (2)
- Branching fractions (2)
- COVID-19 (2)
- Charm physics (2)
- Collectivity (2)
- Correlation (2)
- Decorin (2)
- Diagnostik (2)
- Diffraction (2)
- Electroweak Interaction (2)
- Elliptic flow (2)
- Endovascular repair (2)
- Endovaskuläre Behandlung (2)
- Exotics (2)
- Früherkennung (2)
- HIV (2)
- Heavy-ion collisions (2)
- IR-A (2)
- Jets (2)
- Klinische Ergebnisse (2)
- Leptonic, semileptonic & radiative decays (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Offene Versorgung (2)
- Open repair (2)
- Particle decays (2)
- Pb–Pb collisions (2)
- Proliferation (2)
- Quark-Gluon Plasma (2)
- RHIC (2)
- Register (2)
- Registry (2)
- Richtlinie (2)
- Shear viscosity (2)
- Shell model (2)
- Signaling (2)
- Single electrons (2)
- Single-particle states (2)
- Spectroscopy (2)
- Suicide (2)
- Treatment outcome (2)
- breast cancer (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- screening (2)
- 16 segment AHA model (1)
- 900 GeV (1)
- ALICE detector (1)
- ALL (1)
- Adverse drug reaction (1)
- Alternative oxidase (1)
- Amitriptyline (1)
- Animal personality (1)
- Anti-nuclei (1)
- Anticholinergic (1)
- Antiretroviral therapy (1)
- B-slope (1)
- BESIII detector (1)
- Behavioral reaction norms (1)
- Behavioral specialization (1)
- Behavioral syndromes (1)
- Behavioral type (1)
- Bhabha (1)
- Biogeography (1)
- Biologging (1)
- Biological (1)
- Bipolar disorder (1)
- Born cross section measurement (1)
- CDI (1)
- CP violation (1)
- CVID (1)
- Cardiovascular magnetic resonance (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Charmonium (1)
- Charmonium (-like) (1)
- Children (1)
- Circadian (1)
- Clinical genetics (1)
- Closure (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Comparison with QCD (1)
- Critical point (1)
- Cross section (1)
- Cross sections (1)
- D meson (1)
- DST (1)
- Dark photon (1)
- Dark sector (1)
- Data sharing (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Direct nuclear reactions (1)
- Direct reactions (1)
- Drug susceptibility testing (1)
- Ecology (1)
- Ecophysiology (1)
- Elderly (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electron-pion identification (1)
- European Society for Immunodeficiencies (ESID) (1)
- FOS: Physical sciences (1)
- Fc receptor (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- First-line combination antiretroviral therapy (1)
- Fistula (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flavour Physics (1)
- Florida (1)
- Flow (1)
- Form factors (1)
- GWAS (1)
- Generation Y (1)
- Genetics (1)
- German PID-NET registry (1)
- Groomed jet radius (1)
- Guidelines (1)
- HBT (1)
- Hadron production (1)
- Hadron-Hadron Scattering (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Heavy Ion Experiment (1)
- Heavy Ions (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion (1)
- High Energy Physics - Experiment (hep-ex) (1)
- High-energy neutron detection (1)
- Higher moments (1)
- Human behaviour (1)
- Hyperons (1)
- IgG substitution therapy (1)
- Immunogenetics (1)
- Immunology (1)
- Inclusive spectra (1)
- Induction chemotherapy (1)
- Influenza (1)
- Initial state radiation (1)
- Intensity interferometry (1)
- Interference fragmentation function (1)
- Intra-abdominal infection (1)
- Invisible decays (1)
- Ionisation energy loss (1)
- J/ψ suppression (1)
- Jet substructure (1)
- Jets and Jet Substructure (1)
- Kidney (1)
- Laparostomy (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MLL (1)
- Mesh (1)
- Meta-analysis (1)
- Mid-rapidity (1)
- Mitochondria (1)
- Mitochondrial disease (1)
- Molecular neuroscience (1)
- Monitoring (1)
- Multi-neutron detection (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multimedication (1)
- Multimorbidity (1)
- Multiple parton interactions (1)
- Multiple-indication review (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- NMR spectroscopy (1)
- NTM (1)
- Neolithic (1)
- Neural network (1)
- Neutrinos (1)
- Non-trauma (1)
- Non-tuberculous mycobacteria (1)
- Nonflow (1)
- Nontuberculous mycobacteria (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- Nutrition (1)
- One-nucleon removal (1)
- Open abdomen (1)
- Opportunistic infections (1)
- PID prevalence (1)
- PYTHIA (1)
- Pancreatitis (1)
- Pandemic (1)
- Parainfluenza (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Pb–Pb (1)
- Peritonitis (1)
- Personalized medicine (1)
- Plastic scintillator array (1)
- Pneumonia (1)
- Polypharmacy (1)
- Pre-treatment drug resistance mutations (1)
- Predictability (1)
- Predictive markers (1)
- Properties of Hadrons (1)
- Protease inhibitor therapy (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Psychiatry (1)
- QCD (1)
- Quantum chromodynamics (1)
- Quark Production (1)
- RNA, long noncoding (1)
- Radiative decay (1)
- Rare decays (1)
- Re-exploration (1)
- Reactions with relativistic radioactive beams (1)
- Reintervention (1)
- Relativistic heavy-ion collisions (1)
- Respiratory chain (1)
- Respiratory infections (1)
- Respiratory syncytial virus (1)
- SARS-CoV-2 (1)
- STAR (1)
- Seasonal variation (1)
- Semi-leptonic decays (1)
- Side effects (1)
- Single muons (1)
- SoftDrop (1)
- Solar insolation (1)
- Spectroscopic factors & electromagnetic moments (1)
- Spin alignment (1)
- Splitting function (1)
- Stink bug (1)
- Sub-segmentation (1)
- Sunlight (1)
- Superinfection (1)
- Synthetic (1)
- TR (1)
- Technique (1)
- Techniques Electromagnetic calorimeters (1)
- Thermal model (1)
- Timing (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Transversity (1)
- Trauma (1)
- Trigger (1)
- Upper respiratory tract infection (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Virological failure (1)
- Xenon-based gas mixture (1)
- Y states (1)
- accessory proteins (1)
- acute leukemia (1)
- adaptive cardiac remodelling (1)
- adenocarcinoma (1)
- age (1)
- age-related macular degeneration (1)
- alleles (1)
- alternative oxidase (1)
- angiogenesis (1)
- angiopoietin-2 (1)
- antiepileptic drugs (1)
- autism spectrum disorder (1)
- autistic disorder (1)
- biomarker (1)
- cardiac ischaemia‐reperfusion (1)
- cell-free protein synthesis (1)
- center-of-mass energy (1)
- charmonium-like states (1)
- children and adolescents (1)
- chromosomal translocations (1)
- chronic kidney disease (1)
- cohort study (1)
- copy number polymorphism (1)
- dE/dx (1)
- decision aids (1)
- dimuon (1)
- distress (1)
- distribution (1)
- domestication (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- economy (1)
- ectosomes (1)
- electron transport chain (1)
- electron-positron collision (1)
- epigenomics (1)
- evolution (1)
- excitation transport (1)
- exosomes (1)
- extracellular vesicles (1)
- first record (1)
- gender (1)
- gene flow (1)
- genes (1)
- genetic generalized epilepsy (1)
- genetics (1)
- genome (1)
- genotype (1)
- genotype determination (1)
- germ cell tumors (1)
- glioblastoma (1)
- global change (1)
- guidelines (1)
- habitat destruction (1)
- hadron spectroscopy (1)
- hadronic events (1)
- helicity amplitude analysis (1)
- histology (1)
- hypertension, pulmonary (1)
- inclusive J/ψ decays (1)
- interferon regulatory factor 9 (IRF9) (1)
- intrinsically disordered region (1)
- lamotrigine (1)
- land use (1)
- levetiracetam (1)
- light harvesting networks (1)
- light–energy conversion (1)
- lung cancer (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mouse (1)
- neovascularization, physiologic (1)
- new host record (1)
- non-ST-segment elevation acute coronary syndrome (1)
- nonstructural proteins (1)
- number of J/ψ events (1)
- open quantum systems (1)
- ovary (1)
- p+p collisions (1)
- pharmacoresistance (1)
- phenotype (1)
- primary immunodeficiency (PID) (1)
- quantum transport (1)
- reactive oxygen species (1)
- registry for primary immunodeficiency (1)
- reproducibility (1)
- rigor (1)
- semiconductors (1)
- sex (1)
- single nucleotide polymorphism (1)
- spectra (1)
- standardization (1)
- structural proteins (1)
- surgery (1)
- testis (1)
- tetraquark (1)
- translocation partner genes (1)
- trigger efficiency (1)
- tumor microenvironment (TME) (1)
- type I interferons (IFNs) (1)
- valproic acid (1)
- vascular endothelial growth factor (1)
- versican (VCAN) (1)
- work-life balance (1)
- working conditions (1)
- Λ+c baryon (1)
- Σ hyperon (1)
- √sN N = 2.76 TeV (1)
Institute
Objectives: Multidrug-resistant organisms (MDRO) are considered an emerging threat worldwide. Data covering the clinical impact of MDRO colonization in patients with solid malignancies, however, is widely missing. We sought to determine the impact of MDRO colonization in patients who have been diagnosed with Non-small cell lung cancer (NSCLC) who are at known high-risk for invasive infections.
Materials and methods: Patients who were screened for MDRO colonization within a 90-day period after NSCLC diagnosis of all stages were included in this single-center retrospective study.
Results: Two hundred and ninety-five patients were included of whom 24 patients (8.1%) were screened positive for MDRO colonization (MDROpos) at first diagnosis. Enterobacterales were by far the most frequent MDRO detected with a proportion of 79.2% (19/24). MDRO colonization was present across all disease stages and more present in patients with concomitant diabetes mellitus. Median overall survival was significantly inferior in the MDROpos study group with a median OS of 7.8 months (95% CI, 0.0–19.9 months) compared to a median OS of 23.9 months (95% CI, 17.6–30.1 months) in the MDROneg group in univariate (p = 0.036) and multivariate analysis (P = 0.02). Exploratory analyses suggest a higher rate of non-cancer-related-mortality in MDROpos patients compared to MDROneg patients (p = 0.002) with an increased rate of fatal infections in MDROpos patients (p = 0.0002).
Conclusions: MDRO colonization is an independent risk factor for inferior OS in patients diagnosed with NSCLC due to a higher rate of fatal infections. Empirical antibiotic treatment approaches should cover formerly detected MDR commensals in cases of (suspected) invasive infections.
Background: Few studies have evaluated the impact of pre-treatment drug resistance (PDR) on response to combination antiretroviral treatment (cART) in children. The objective of this joint EuroCoord-CHAIN-EPPICC/PENTA project was to assess the prevalence of PDR mutations and their association with virological outcome in the first year of cART in children.
Methods: HIV-infected children <18 years initiating cART between 1998 and 2008 were included if having at least one genotypic resistance test prior to cART initiation. We used the World Health Organization 2009 resistance mutation list and Stanford algorithm to infer resistance to prescribed drugs. Time to virological failure (VF) was defined as the first of two consecutive HIV-RNA > 500 copies/mL after 6 months cART and was assessed by Cox proportional hazards models. All models were adjusted for baseline demographic, clinical, immunology and virology characteristics and calendar period of cART start and initial cART regimen.
Results: Of 476 children, 88 % were vertically infected. At cART initiation, median (interquartile range) age was 6.6 years (2.1–10.1), CD4 cell count 297 cells/mm3 (98–639), and HIV-RNA 5.2 log10copies/mL (4.7–5.7). Of 37 children (7.8 %, 95 % confidence interval (CI), 5.5–10.6) harboring a virus with ≥1 PDR mutations, 30 children had a virus resistant to ≥1 of the prescribed drugs. Overall, the cumulative Kaplan-Meier estimate for virological failure was 19.8 % (95 %CI, 16.4–23.9). Cumulative risk for VF tended to be higher among children harboring a virus with PDR and resistant to ≥1 drug prescribed than among those receiving fully active cART: 32.1 % (17.2–54.8) versus 19.4 % (15.9–23.6) (P = 0.095). In multivariable analysis, age was associated with a higher risk of VF with a 12 % reduced risk per additional year (HR 0.88; 95 %CI, 0.82–0.95; P < 0.001).
Conclusions: PDR was not significantly associated with a higher risk of VF in children in the first year of cART. The risk of VF decreased by 12 % per additional year at treatment initiation which may be due to fading of PDR mutations over time. Lack of appropriate formulations, in particular for the younger age group, may be an important determinant of virological failure.
Background: Patients with chronic kidney disease (CKD) are at high risk of myocardial infarction. Cardiac troponins are the biomarkers of choice for the diagnosis of acute myocardial infarction (AMI) without ST‐segment elevation (NSTE). In patients with CKD, troponin levels are often chronically elevated, which reduces their diagnostic utility when NSTE‐AMI is suspected. The aim of this study was to derive a diagnostic algorithm for serial troponin measurements in patients with CKD and suspected NSTE‐AMI.
Methods and Results: Two cohorts, 1494 patients from a prospective cohort study with high‐sensitivity troponin I (hs‐cTnI) measurements and 7059 cases from a clinical registry with high‐sensitivity troponin T (hs‐cTnT ) measurements, were analyzed. The prospective cohort comprised 280 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2). The registry data set contained 1581 CKD patients. In both cohorts, CKD patients were more likely to have adjudicated NSTE‐AMI than non‐CKD patients. The specificities of hs‐cTnI and hs‐cTnT to detect NSTE‐AMI were reduced with CKD (0.82 versus 0.91 for hs‐cTnI and 0.26 versus 0.73 for hs‐cTnT) but could be restored by applying optimized cutoffs to either the first or a second measurement after 3 hours. The best diagnostic performance was achieved with an algorithm that incorporates serial measurements and rules in or out AMI in 69% (hs‐cTnI) and 55% (hs‐cTnT) of CKD patients.
Conclusions: The diagnostic performance of high‐sensitivity cardiac troponins in patients with CKD with suspected NSTE‐AMI is improved by use of an algorithm based on admission troponin and dynamic changes in troponin concentration.
Patients with acute myeloid leukemia (AML) are often exposed to broad-spectrum antibiotics and thus at high risk of Clostridioides difficile infections (CDI). As bacterial infections are a common cause for treatment-related mortality in these patients, we conducted a retrospective study to analyze the incidence of CDI and to evaluate risk factors for CDI in a large uniformly treated AML cohort. A total of 415 AML patients undergoing intensive induction chemotherapy between 2007 and 2019 were included in this retrospective analysis. Patients presenting with diarrhea and positive stool testing for toxin-producing Clostridioides difficile were defined to have CDI. CDI was diagnosed in 37 (8.9%) of 415 AML patients with decreasing CDI rates between 2013 and 2019 versus 2007 to 2012. Days with fever, exposition to carbapenems, and glycopeptides were significantly associated with CDI in AML patients. Clinical endpoints such as length of hospital stay, admission to ICU, response rates, and survival were not adversely affected. We identified febrile episodes and exposition to carbapenems and glycopeptides as risk factors for CDI in AML patients undergoing induction chemotherapy, thereby highlighting the importance of interdisciplinary antibiotic stewardship programs guiding treatment strategies in AML patients with infectious complications to carefully balance risks and benefits of anti-infective agents.
Background: Predicted increases in suicide were not generally observed in the early months of the COVID-19 pandemic. However, the picture may be changing and patterns might vary across demographic groups. We aimed to provide a timely, granular picture of the pandemic's impact on suicides globally.
Methods: We identified suicide data from official public-sector sources for countries/areas-within-countries, searching websites and academic literature and contacting data custodians and authors as necessary. We sent our first data request on 22nd June 2021 and stopped collecting data on 31st October 2021. We used interrupted time series (ITS) analyses to model the association between the pandemic's emergence and total suicides and suicides by sex-, age- and sex-by-age in each country/area-within-country. We compared the observed and expected numbers of suicides in the pandemic's first nine and first 10-15 months and used meta-regression to explore sources of variation.
Findings: We sourced data from 33 countries (24 high-income, six upper-middle-income, three lower-middle-income; 25 with whole-country data, 12 with data for area(s)-within-the-country, four with both). There was no evidence of greater-than-expected numbers of suicides in the majority of countries/areas-within-countries in any analysis; more commonly, there was evidence of lower-than-expected numbers. Certain sex, age and sex-by-age groups stood out as potentially concerning, but these were not consistent across countries/areas-within-countries. In the meta-regression, different patterns were not explained by countries’ COVID-19 mortality rate, stringency of public health response, economic support level, or presence of a national suicide prevention strategy. Nor were they explained by countries’ income level, although the meta-regression only included data from high-income and upper-middle-income countries, and there were suggestions from the ITS analyses that lower-middle-income countries fared less well.
Interpretation: Although there are some countries/areas-within-countries where overall suicide numbers and numbers for certain sex- and age-based groups are greater-than-expected, these countries/areas-within-countries are in the minority. Any upward movement in suicide numbers in any place or group is concerning, and we need to remain alert to and respond to changes as the pandemic and its mental health and economic consequences continue.
Background: The angiogenic function of endothelial cells is regulated by numerous mechanisms, but the impact of long noncoding RNAs (lncRNAs) has hardly been studied. We set out to identify novel and functionally important endothelial lncRNAs.
Methods: Epigenetically controlled lncRNAs in human umbilical vein endothelial cells were searched by exon-array analysis after knockdown of the histone demethylase JARID1B. Molecular mechanisms were investigated by RNA pulldown and immunoprecipitation, mass spectrometry, microarray, several knockdown approaches, CRISPR-Cas9, assay for transposase-accessible chromatin sequencing, and chromatin immunoprecipitation in human umbilical vein endothelial cells. Patient samples from lung and tumors were studied for MANTIS expression.
Results: A search for epigenetically controlled endothelial lncRNAs yielded lncRNA n342419, here termed MANTIS, as the most strongly regulated lncRNA. Controlled by the histone demethylase JARID1B, MANTIS was downregulated in patients with idiopathic pulmonary arterial hypertension and in rats treated with monocrotaline, whereas it was upregulated in carotid arteries of Macaca fascicularis subjected to atherosclerosis regression diet, and in endothelial cells isolated from human glioblastoma patients. CRISPR/Cas9-mediated deletion or silencing of MANTIS with small interfering RNAs or GapmeRs inhibited angiogenic sprouting and alignment of endothelial cells in response to shear stress. Mechanistically, the nuclear-localized MANTIS lncRNA interacted with BRG1, the catalytic subunit of the switch/sucrose nonfermentable chromatin-remodeling complex. This interaction was required for nucleosome remodeling by keeping the ATPase function of BRG1 active. Thereby, the transcription of key endothelial genes such as SOX18, SMAD6, and COUP-TFII was regulated by ensuring efficient RNA polymerase II machinery binding.
Conclusion: MANTIS is a differentially regulated novel lncRNA facilitating endothelial angiogenic function.
Measurement of the 244Cm and 246Cm neutron-induced capture cross sections at the n_TOF facility
(2019)
The neutron capture reactions of the 244Cm and 246Cm isotopes open the path for the formation of heavier Cm isotopes and heavier elements such as Bk and Cf in a nuclear reactor. In addition, both isotopes belong to the minor actinides with a large contribution to the decay heat and to the neutron emission in irradiated fuels. There are only two previous 244Cm and 246Cm capture cross section measurements: one in 1969 using a nuclear explosion [1] and the most recent data measured at J-PARC in 2010 [2]. The data for both isotopes are very scarce due to the difficulties in performing the measurements: high intrinsic activity of the samples and limited facilities capable of providing isotopically enriched samples.
We have measured both neutron capture cross sections at the n_TOF Experimental Area 2 (EAR-2) with three C6 D6 detectors and also at Area 1 (EAR-1) with the TAC. Preliminary results assessing the quality and limitations (back-ground subtraction, measurement technique and counting statistics) of this new experimental datasets are presented and discussed.
The design and operation of innovative nuclear systems requires a better knowledge of the capture and fission cross sections of the Pu isotopes. For the case of capture on 242Pu, a reduction of the uncertainty in the fast region down to 8-12% is required. Moreover, aiming at improving the evaluation of the fast energy range in terms of average parameters, the OECD NEA High Priority Request List (HPRL) requests high-resolution capture measurements with improved accuracy below 2 keV. The current uncertainties also affect the thermal point, where previous experiments deviate from each other by 20%. A fruitful collaboration betwen JGU Mainz and HZ Dresden-Rossendorf within the EC CHANDA project resulted in a 242Pu sample consisting of a stack of seven fission-like targets making a total of 95(4) mg of 242Pu electrodeposited on thin (11.5 μm) aluminum backings. This contribution presents the results of a set of measurements of the 242Pu(n, γ) cross section from thermal to 500 keV combining different neutron beams and techniques. The thermal point was determined at the Budapest Research Reactor by means of Neutron Activation Analysis and Prompt Gamma Analysis, and the resolved (1 eV - 4 keV) and unresolved (1 - 500 keV) resonance regions were measured using a set of four Total Energy detectors at the CERN n_TOF-EAR1.
A wide variety of enzymatic pathways that produce specialized metabolites in bacteria, fungi and plants are known to be encoded in biosynthetic gene clusters. Information about these clusters, pathways and metabolites is currently dispersed throughout the literature, making it difficult to exploit. To facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters, we propose the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard.
Investigators in the cognitive neurosciences have turned to Big Data to address persistent replication and reliability issues by increasing sample sizes, statistical power, and representativeness of data. While there is tremendous potential to advance science through open data sharing, these efforts unveil a host of new questions about how to integrate data arising from distinct sources and instruments. We focus on the most frequently assessed area of cognition - memory testing - and demonstrate a process for reliable data harmonization across three common measures. We aggregated raw data from 53 studies from around the world which measured at least one of three distinct verbal learning tasks, totaling N = 10,505 healthy and brain-injured individuals. A mega analysis was conducted using empirical bayes harmonization to isolate and remove site effects, followed by linear models which adjusted for common covariates. After corrections, a continuous item response theory (IRT) model estimated each individual subject’s latent verbal learning ability while accounting for item difficulties. Harmonization significantly reduced inter-site variance by 37% while preserving covariate effects. The effects of age, sex, and education on scores were found to be highly consistent across memory tests. IRT methods for equating scores across AVLTs agreed with held-out data of dually-administered tests, and these tools are made available for free online. This work demonstrates that large-scale data sharing and harmonization initiatives can offer opportunities to address reproducibility and integration challenges across the behavioral sciences.
The elliptic-flow ratio of neutrons with respect to protons or light complex particles in reactions of heavy ions at pre-relativistic energies has been proposed as an observable sensitive to the strength of the symmetry term of the nuclear equation of state at supra-saturation densities. In the ASY-EOS experiment at the GSI laboratory, flows of neutrons and light charged particles were measured for 197Au+197Au collisions at 400 MeV/nucleon. Flow results obtained for the Au+Au system, in comparison with predictions of the UrQMD transport model, confirm the moderately soft to linear density dependence of the symmetry energy deduced from the earlier FOPI-LAND data.
Aim: Pharmacoresistance is a major burden in epilepsy treatment. We aimed to identify genetic biomarkers in response to specific antiepileptic drugs (AEDs) in genetic generalized epilepsies (GGE). Materials & methods: We conducted a genome-wide association study (GWAS) of 3.3 million autosomal SNPs in 893 European subjects with GGE – responsive or nonresponsive to lamotrigine, levetiracetam and valproic acid. Results: Our GWAS of AED response revealed suggestive evidence for association at 29 genomic loci (p <10-5) but no significant association reflecting its limited power. The suggestive associations highlight candidate genes that are implicated in epileptogenesis and neurodevelopment. Conclusion: This first GWAS of AED response in GGE provides a comprehensive reference of SNP associations for hypothesis-driven candidate gene analyses in upcoming pharmacogenetic studies.